High-dose growth hormone therapy in idiopathic short stature

Hormone Research

Volumn 49, Issue SUPPL. 2, 1998, Pages 67-72

  Kamp, G A ^a   Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Growth; Growth hormone; Short stature

Indexed keywords

GROWTH HORMONE;

BODY HEIGHT; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; HORMONAL THERAPY; HUMAN; IDIOPATHIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHORT STATURE;

BODY HEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 0031717434     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053090     Document Type: Conference Paper

References (47)

1. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al: Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80: 1532-1540.
2. Wit JM, Kamp GA, Rikken B: Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996;39:295-302.
3. De Muinck Keizer-Schrama S, Rikken B, Hokken-Koelega A, Wit JM, Drop S, Dutch Growth Hormone Working Group: Comparative effect of two doses of growth hormone in growth hormone deficient children: Growth, predictive factors, safety parameters. Arch Dis Child 1994;71:12-18.
4. Sotos JF: Overgrowth. VI. Genetic syndromes and other disorders associated with overgrowth. Clin Pediatr (Phila) 1997;36:157-170.
5. Stokvis WH, Wit JM, Van den Brande JL: A 9 year old boy with giantism. Int Symp on Growth and Growth Disorders, Brussels, 1988, pp 28-29.
6. Lu PW, Silink M, Johnston I, Cowell CT, Jimenez M: Pituitary gigantism. Arch Dis Child 1992;67:1039-1041.
7. Gelber SJ, Heffez DS, Donohoue PA: Pituitary gigantism caused by growth hormone excess from infancy. J Pediatr 1992;120:931-934.
8. Rose SR, Municchi G, Barnes KM, et al: Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 1991;73:428-435.
9. Costin G, Ratner-Kaufman F, Brasel JA: Growth hormone secretory dynamics in subjects with normal stature. J Pediatr 1989;115: 537-544.
10. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bereu BB: Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984;251:2223-2230.
11. Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB Jr: The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 1988;319:201-207.
12. Lanes R: Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children. Am J Dis Child 1989;143:1284-1286.
13. Ranke MB: Towards a consensus on the definition of idiopathic short stature. Summary. Horm Res 1996;45(suppl 2):64-66.
14. Rekers-Mombarg LT, Wit JM, Massa GG, et al: Spontaneous growth in idiopathic short stature. European Study Group. Arch Dis Child 1996;75:175-180.
15. Chaussain JL, Colle M, Ducret JP: Adult height in children with prepubertal short stature secondary to intrauterine growth retardation. Acta Paediatr Suppl 1994;399:72-73.
16. Blum WF, Cotterill AM, Postelvinay MC, et al: Improvement of diagnostic criteria in growth hormone insensitivity syndrome: Solutions and pitfalls. Acta Paediatr 1994;399:117-124.
17. Savage MO, Woods KA: The investigation of growth hormone insensitivity. Clin Endocrinol (Oxf)1996;45:257-260.
18. Thalange NK, Price DA, Gill MS, Whatmore AJ, Addison GM, Clayton PE: Insulin-like growth factor binding protein-3 generation: An index of growth hormone insensitivity. Pediatr Res 1996;39:849-855.
19. Attie KM, Carlsson LMS, Rundle AC, Sherman BM: Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. J Pediatr 1995;127:244-250.
20. Carlsson LMS, Attie KM, Compton PG, Vitangcol RV, Merimee TJ: Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study. J Clin Endocrinol Metab 1994;78:1325-1330.
21. Rogol AD, Breen TJ, Attie KM: National Cooperative Growth Study substudy. II. Do growth hormone levels from serial sampling add important diagnostic information? J Pediatr 1996;128(suppl):42-46.
22. Goddard AD, Covello R, Luoh SM, et al: Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group (see comments). N Engl J Med 1995;333:1093-1098.
23. De Wall WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL: Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf) 1994;41:621-630.
24. Albertsson-Wikland K, Rosberg S: Analysis of 24-hour growth hormone profiles in children: Relation to growth. J Clin Endocrinol Metab 1988;67:493-500.
25. Wit JM, Rietveld DH, Drop SL, et al: A controlled trial of methionyl growth hormone therapy in prepubertal children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Acta Paediatr Scand 1989;78:426-435.
26. Hindmarsh PC, Matthews DR, Brain C, Pringle PJ, Brook CGD: The application of deconvolution analysis to elucidate the pulsatile nature of growth hormone secretion using a variable half-life of growth hormone. Clin Endocri-nol 1990;32:739-747.
27. Hintz RL: Growth hormone treatment of idiopathic short stature. Horm Res 1996;46:208-214.
28. Hindmarsh PC, Brook CGD: Final height of short normal children treated with growth hormone. Lancet 1996;348:13-16.
29. Hopwood NJ, Hintz RL, Gertner JM, et al: Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993;123:215-222.
30. Wit JM, Boersma B, de Muinck Keizer-Schrama SMPF, et al: Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Clin Endocrinol 1995;42:365-372.
31. Albertsson-Wikland K: Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr 1993; 82(suppl 391): 75-78.
32. Moore WV, Moore KC, Gifford R, Hollowell JG, Donaldson DL: Long-term treatment with growth hormone of children with short stature and normal growth hormone secretion. J Pediatr 1992;120:702-708.
33. Rekers-Mombarg LTM, Massa GG, Wit JM, et al: Growth hormone therapy with three dosage regimens in children with idiopathic short stature. J Pediatr 1997; in press.
34. Lesage C, Walker J, Landier F, Chatelain P, Chaussain JL, Bougneres PF: Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr 1991;119:29-34.
35. Barton JS, Gardineri HM, Cullen S, Hindmarsh PC, Brook CG, Preece MA: The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Clin Endocrinol (Oxf) 1995;42:619-626.
36. Chatelain P, Job JC, Blanchard J, et al: Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metab 1994;78:1454-1460.
37. de Zegher F, Maes M, Heinrichs C, et al: High-dose growth hormone therapy for short children born small for gestational age. Belgian Study Group for Paediatric Endocrinology. Acta Paediatr Suppl 1994;399:77.
38. de Zegher F, Maes M, Gargosky SE, et al: High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab 1996;81:1887-1892.
39. Job JC, Chaussain JL, Job B, et al: Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 1996;39:354-359.
40. Guyda HJ: Growth hormone treatment of non-growth hormone deficient subjects: The International Task Force report. Clin Pediatr Endocrinol 1996;5(suppl 7):11-18.
41. Bierich JR, Nolte K, Drews K, Brugmann G: Constitutional delay of growth and adolescence. Results of short-term and long-term treatment with GH. Acta Endocrinol 1992; 127:392-396.
42. Loche S, Cambiaso P, Setzu S, et al: Final height after growth hormone therapy in non-growth hormone-deficient children with short stature. J Pediatr 1994;125:196-200.
43. Kawai M, Momoi T, Yorifuji T, Yamanaka C, Sasaki H, Furusho K: Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency (see comments). J Pediatr 1997;130:205-209.
44. Rekers-Mombarg LTM, Massa GG, Wit JM: Final height of short normal children treated with growth hormone. Lancet 1996;348:681.
45. Zadik Z, Chalew SA, Kowarski A: The definition of a spontaneous growth hormone (GH) peak: Studies in normally growing and GH-deficient children. J Clin Endocrinol Metab 1992;74:801-805.
46. Zadik Z, Chalew S, Zung A, et al: Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classical growth hormone deficiency. J Pediatr 1994;125:189-195.
47. Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965 part II. Arch Dis Child 1966;41:613-635.